1. Home
  2. MICC vs BIO Comparison

MICC vs BIO Comparison

Compare MICC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MICC

The Magnum Ice Cream Company N.V. Ordinary Shares

SELL

Current Price

$19.74

Market Cap

12.2B

ML Signal

SELL

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

SELL

Current Price

$360.58

Market Cap

10.3B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
MICC
BIO
Founded
2025
1952
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.2B
10.3B
IPO Year
2025
1994

Fundamental Metrics

Financial Performance
Metric
MICC
BIO
Price
$19.74
$360.58
Analyst Decision
Sell
Hold
Analyst Count
4
3
Target Price
$19.77
★ $356.67
AVG Volume (30 Days)
★ 795.9K
232.9K
Earning Date
02-12-2027
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 142.61
EPS
N/A
★ 11.25
Revenue
N/A
★ $2,583,200,000.00
Revenue This Year
$6.59
N/A
Revenue Next Year
$4.61
$1.86
P/E Ratio
★ $28.55
$32.60
Revenue Growth
N/A
★ 0.65
52 Week Low
$12.94
$236.73
52 Week High
$20.69
$396.23

Technical Indicators

Market Signals
Indicator
MICC
BIO
Relative Strength Index (RSI) 54.71 42.05
Support Level $19.00 $354.27
Resistance Level $20.00 $392.10
Average True Range (ATR) 0.33 12.87
MACD -0.01 -1.48
Stochastic Oscillator 60.33 18.57

Price Performance

Historical Comparison
MICC
BIO

About MICC The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Co., spun off from Unilever, manufactures and sells a broad portfolio of ice cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice cream brands: Heartbrand (an umbrella brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: